| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 683564 | 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- | 0.0361455178924431 | 0.37294124 |
| NSC 685865 | Null | 0.0361455178924431 | -0.048587165 |
| NSC 686556 | Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- | 0.0361455178924431 | 0.020421863 |
| NSC 688526 | Null | 0.0361455178924431 | -0.072848377 |
| NSC 694234 | Null | 0.0361455178924431 | -0.067326149 |
| NSC 699092 | Null | 0.0361455178924431 | 0.21115811 |
| NSC 702045 | 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- | 0.0361455178924431 | 0.30743856 |
| NSC 723906 | 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline | 0.0361455178924431 | 0.34156534 |
| NSC 724784 | (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 | 0.0361455178924431 | 0.30812152 |
| NSC 750493 | 2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one | 0.0393863597626316 | 0.40791543 |